InvestorsHub Logo
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

Re: GlefdarLivermore post# 11117

Friday, 10/22/2021 11:14:12 AM

Friday, October 22, 2021 11:14:12 AM

Post# of 13742
Paytience pays QNTA

In my opinion, the years of research are culminating together and moving in the right direction in order to get escozine approved in proper fashion - not only with the fda / US but also abroad.
In regards to polarization technology, Proof of concept of the polarization technology was kept under the radar purposefully by quietly rolling out the Aelia muscle rub in order to be able to show the increased potency / efficacy of a product of which the polarization technology was used to produce said product. Now with proof of concept in hand and in the market place, add in the latest data showing significant increase in Advil potency, they have a solid data set to bring to companies showing how and why their technology could be utilized by other companies.

I suggest to all longs and new investors to go back and relisten to Conference calls and peruse the DD ..

Here’s an article showing the arduous process of new drugs … it takes a long time from start to the finish line … it’s been years already … while it’s seemingly feeling like an eternity … a few months in the grand scheme of things is negligible..

I’m long, and have added more ..

GLTA QNTA $$

https://www.drugs.com/fda-approval-process.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.